Uysal Gulsum, Adiguzel Cevdet, Okmen Firat, Hejazi Ghaith
Department of Obstetrics and Gynecology, Republic of Turkey Ministry of Health Adana City Hospital, Adana, Turkey.
Department of Obstetrics and Gynecology, Ege University School of Medicine, Bornova, Izmir, Turkey.
Medicine (Baltimore). 2025 Aug 15;104(33):e43928. doi: 10.1097/MD.0000000000043928.
The aim of this study was to analyze the inflammatory markers, including C-reactive protein to albumin (ALB) ratios (CAR), and fibrinogen to ALB ratios (FAR) of pregnant women who visited the obstetrics clinic of our hospital and were diagnosed with previable preterm prelabor rupture of membranes (PPROM), defined as delivery between 200/7 and 256/7 weeks at the border of fetal viability, and to compare the scores with those of the healthy control group. We also aimed to determine the utility of these laboratory scores in women who aborted or continued their pregnancy and live births. Patients aged 18 to 45 diagnosed with previable PPROM between 16 and 22 weeks with singleton live pregnancies were included. Patients with uterine or fetal anomalies, multiple pregnancies, or history of chronic inflammatory disease were excluded. A total of 79 pregnant women were divided into 2 groups: healthy pregnant controls (control, n = 30) and patients diagnosed with previable PPROM (n = 49). 35/49 (71.4%) preferred expectant management. Of these 35 patients 14/35 (40%) had live birth and 21/35 (60%) had abortions. C-reactive protein (23 mg/dl), CAR (0.84), and FAR values were statistically significantly higher, whereas ALB levels (34.2 g/L) were lower in previable PPROM patients than in controls (P < .001). More importantly, our findings indicated that the FAR at admission (1.4, P < .001) was positively correlated with abortion in previable PPROM among the patients during expectant management. Receiver operating characteristic analysis revealed that the area under the curve for FAR was 0.840 (P < .001; sensitivity, 76.2%; specificity, 85.7%), and FAR presented the highest predictive value with a 1.18 cut point for abortion in previable PPROM. While the CAR value was significantly higher in patients with PPROM in the patient and control groups, the FAR value was significantly higher in patients who aborted in the PPROM group than in those with live pregnancies. Routine markers that are readily derived in daily clinical practice, such as the FAR, may have clinical significance in evaluating predicting prognosis in previable PPROM.
本研究旨在分析我院产科门诊就诊且被诊断为早期未存活早产胎膜早破(PPROM)(定义为在胎儿存活临界期20⁰/₇至25⁶/₇周之间分娩)的孕妇的炎症标志物,包括C反应蛋白与白蛋白(ALB)比值(CAR)以及纤维蛋白原与ALB比值(FAR),并将这些指标与健康对照组进行比较。我们还旨在确定这些实验室指标在流产或继续妊娠及活产的女性中的效用。纳入年龄在18至45岁、单胎活孕、在16至22周被诊断为早期未存活PPROM的患者。排除有子宫或胎儿异常、多胎妊娠或慢性炎症疾病史的患者。共79名孕妇分为两组:健康孕妇对照组(对照组,n = 30)和被诊断为早期未存活PPROM的患者(n = 49)。49例中有35例(71.4%)选择期待治疗。在这35例患者中(35例),14例(40%)活产,21例(60%)流产。早期未存活PPROM患者的C反应蛋白(23mg/dl)、CAR(0.84)和FAR值在统计学上显著更高,而ALB水平(34.2g/L)低于对照组(P <.001)。更重要的是,我们的研究结果表明,期待治疗期间早期未存活PPROM患者入院时的FAR(1.4,P <.001)与流产呈正相关。受试者工作特征分析显示,FAR的曲线下面积为0.840(P <.001;敏感性为76.2%;特异性为85.7%),FAR对早期未存活PPROM流产的预测价值最高,切点为1.18。虽然患者组和对照组中PPROM患者的CAR值显著更高,但PPROM组中流产患者的FAR值显著高于活产患者。日常临床实践中容易获得的常规指标,如FAR,在评估早期未存活PPROM的预后方面可能具有临床意义。